TechCrunch – September 2023
At Stimvia, we believe that everyone deserves access to safe and effective medical treatments.
We’re committed to developing our neuromodulation technology to the highest standards…
PDF article: …. link HERE
CzechCrunch magazine – July 2023
At Stimvia, we believe that everyone deserves access to safe and effective medical treatments.
We’re committed to developing our neuromodulation technology to the highest standards…
link: ….. link HERE
The Journal of Urology – April 2023
Our recent study, led by Jan Krhut and featuring team members Michal Rejchrt, Martin Slovak, Roman V. Dvorak, Lukas Peter, Bertil FM Blok and Peter Zvara, compared the effectiveness of the URIS neuromodulation system and Solifenacin for treating overactive bladder (OAB) has been published in the prestigious journal The Journal of Urology.
link: ….. link HERE
Sustainability – EN ISO 14001:2025 – March 2023
Our URIS® device improves the quality of life of incontinence patients while protecting the environment! Stimvia has successfully passed a sustainability audit regarding its production processes and the company. This audit earned us certification according to the European standard EN ISO 14001:2025, which confirms our commitment to environmental responsibility.
Delloite Fast 50 CE – December 2022
Awards for products with a revolutionary impact on the market, Stimvia was awarded as IMPACT STARS
links: ….. Deloitte Fast 50 CE
Věda a výzkum – November 2022
Czech company comes with unique technology for the treatment of chronic disease. …
links: …..the “věda a výzkum” post
archive: ….PDF archive
Czech Industry magazine- 2022
Česká společnost Stimvia vyvinula průlomovou technologii na léčbu nemocí spojených s centrální nervovou soustavou. …
links: …..Czech industry post
archive: ….PDF archive
Victory in the 4DigitalHealth accelerator – January 2021
The winner of the 4DigitalHealth accelerator is the Czech startup Tesla Medical. …
links: …..the “Svou cestou” post
archive: ….PDF archive